AI assistant
Sending…
GILEAD SCIENCES, INC. — Director's Dealing 2019
Apr 1, 2019
29828_dirs_2019-04-01_2afbe6c1-a690-4530-a083-1300bfe4f08a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-03-28
Reporting Person: Whitley Richard James (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-28 | Phantom Stock | $0 | A | 66.3251 | Acquired | Common Stock (66.3251) | Direct |
Footnotes
F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.
F2: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.
F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.
More from GILEAD SCIENCES, INC.
Regulatory Filings
2026
May 20
Prospectus
2026
May 18
Regulatory Filings
2026
May 14
Prospectus
2026
May 14
Regulatory Filings
2026
May 8
Registration Form
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 30